Members of AdvaMed told the House Commerce Committee’s subcommittee on health and environment last month that new medical technologies are reaching patients too slowly because of delays in the Health Care Financing Administration’s coding,
Members of AdvaMed told the House Commerce Committees subcommittee on health and environment last month that new medical technologies are reaching patients too slowly because of delays in the Health Care Financing Administrations coding, coverage, and payment systems.
Patients can wait four-and-a-half years or more to be diagnosed by or treated with new medical technologies because of Medicare procedures, said David Fleming, group senior vice president of Genzyme Corp. and chair of the AdvaMed Board Committee on Payment and Health Care Delivery, at the hearing.
AdvaMed has been actively working to pass the Medicare Patient Access to Technology Act. The bill would eliminate reimbursement and coding delays, the association believes.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.